evolocumab
amgen
['fourier']
it was terrific to discuss rwe on pcsk9 inhibitors in clinical practice with the great at #esccongress2022 ! we need to improve a lot , specially after results of fourier-ole 
Preventive Cardiologist and Lipidologist  trying to reduce the burden of ASCVD in FH @hipercol_brasil,  @atherosociety, @HFiberoamerica  & @FHSCGlobal